Gabriëls, R.Y.; Bourgonje, A.R.; von Martels, J.Z.H.; Blokzijl, T.; Weersma, R.K.; Galinsky, K.; Juarez, J.; Faber, K.N.; Kats-Ugurlu, G.; Dijkstra, G.
Mucosal Eosinophil Abundance in Non-Inflamed Colonic Tissue Is Associated with Response to Vedolizumab Induction Therapy in Inflammatory Bowel Disease. J. Clin. Med. 2022, 11, 4141.
https://doi.org/10.3390/jcm11144141
AMA Style
Gabriëls RY, Bourgonje AR, von Martels JZH, Blokzijl T, Weersma RK, Galinsky K, Juarez J, Faber KN, Kats-Ugurlu G, Dijkstra G.
Mucosal Eosinophil Abundance in Non-Inflamed Colonic Tissue Is Associated with Response to Vedolizumab Induction Therapy in Inflammatory Bowel Disease. Journal of Clinical Medicine. 2022; 11(14):4141.
https://doi.org/10.3390/jcm11144141
Chicago/Turabian Style
Gabriëls, Ruben Y., Arno R. Bourgonje, Julius Z. H. von Martels, Tjasso Blokzijl, Rinse K. Weersma, Kevin Galinsky, Julius Juarez, Klaas Nico Faber, Gursah Kats-Ugurlu, and Gerard Dijkstra.
2022. "Mucosal Eosinophil Abundance in Non-Inflamed Colonic Tissue Is Associated with Response to Vedolizumab Induction Therapy in Inflammatory Bowel Disease" Journal of Clinical Medicine 11, no. 14: 4141.
https://doi.org/10.3390/jcm11144141
APA Style
Gabriëls, R. Y., Bourgonje, A. R., von Martels, J. Z. H., Blokzijl, T., Weersma, R. K., Galinsky, K., Juarez, J., Faber, K. N., Kats-Ugurlu, G., & Dijkstra, G.
(2022). Mucosal Eosinophil Abundance in Non-Inflamed Colonic Tissue Is Associated with Response to Vedolizumab Induction Therapy in Inflammatory Bowel Disease. Journal of Clinical Medicine, 11(14), 4141.
https://doi.org/10.3390/jcm11144141